Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge
about
Adjuvants: Classification, Modus Operandi, and LicensingDirect Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future TherapiesProtection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1.Viral immune evasion in dengue: toward evidence-based revisions of clinical practice guidelines.Antigen targeting to dendritic cells allows the identification of a CD4 T-cell epitope within an immunodominant Trypanosoma cruzi antigenThe presence of T cell epitopes is important for induction of antibody responses against antigens directed to DEC205+ dendritic cells.Dendritic Cell Targeting Effectively Boosts T Cell Responses Elicited by an HIV Multiepitope DNA Vaccine.Targeting human dendritic cells in situ to improve vaccines.A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone.Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.Vaccines licensed and in clinical trials for the prevention of dengue.Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccinesOld and new adjuvants.In vivo targeting of protein antigens to dendritic cells using anti-DEC-205 single chain antibody improves HIV Gag specific CD4(+) T cell responses protecting from airway challenge with recombinant vaccinia-gag virus.CpG Oligodeoxinucleotides and Flagellin Modulate the Immune Response to Antigens Targeted to CD8α+ and CD8α- Conventional Dendritic Cell Subsets.Recent Developments in Recombinant Protein-Based Dengue Vaccines
P2860
Q26747586-D626D130-5911-469F-88AD-40A9E2906393Q26752558-CC4333A8-E83A-4D07-B88A-F40535DCF3E9Q33414156-EEC25868-8669-4A14-B7F8-0D01CAB7068EQ35033144-79DD53E3-024D-44BD-996C-D6D755969F4EQ35095495-01833065-5BCC-4331-B815-4C57F1391F80Q37522784-65D89E86-A05F-40A4-B450-BD3909E60913Q37628515-627BEFE8-ECFE-4BC5-9BF8-6E3FB4489D89Q38235001-86388586-7FF5-45B8-9C4B-C6E1AAF36B8EQ38658737-12E7A45E-8F20-417C-B46E-3DCA194DE30AQ38871575-C7CA85A7-BABA-418A-8D78-69A8854626E5Q39172722-25742ADF-47E0-4011-9D87-A6D99D3EB04CQ39448911-47FB6FF5-DCF4-407D-8EC5-0EB358BACCDDQ39451745-6518ECE2-E33D-4A85-B6C6-B8431ED4419AQ40214060-9C3ABBDF-F485-4B7F-869D-80B9901EB9B1Q47137521-A7E08062-F90D-43A9-863E-1B12B8E3F1AEQ56960671-9582281A-8882-4555-8150-402DE2D09AFD
P2860
Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Targeting the non-structural p ...... nity to lethal virus challenge
@ast
Targeting the non-structural p ...... nity to lethal virus challenge
@en
Targeting the non-structural p ...... nity to lethal virus challenge
@nl
type
label
Targeting the non-structural p ...... nity to lethal virus challenge
@ast
Targeting the non-structural p ...... nity to lethal virus challenge
@en
Targeting the non-structural p ...... nity to lethal virus challenge
@nl
prefLabel
Targeting the non-structural p ...... nity to lethal virus challenge
@ast
Targeting the non-structural p ...... nity to lethal virus challenge
@en
Targeting the non-structural p ...... nity to lethal virus challenge
@nl
P2093
P2860
P1476
Targeting the non-structural p ...... nity to lethal virus challenge
@en
P2093
Ada M B Alves
Antonio J S Gonçalves
Elaine C M Vicentin
Eline V Rampazo
Hugo R Henriques
Jaime H Amorim
Kelly N S Amorim
Luís C S Ferreira
Marcio M Yamamoto
Raquel H Panatieri
P2860
P356
10.1371/JOURNAL.PNTD.0002330
P407
P577
2013-07-18T00:00:00Z